@samfiodiving
Funds raised get ANP to the end of the trial AND the 6 month open label extension (OLE).
I heard SPP will allow shareholders to get some but quite limited. Maybe $2m max. Do the math. Even 500 shareholders means $4k each.
Sam.. you will find my former price targets were a high and low range based on probability. $40 was a 1% chance. My high low was $2 to $40 and that was when we had approx 450m shares on issue. Now we have approx 900m. NEU is the template here as management have stated.
NEU were $250m during recruitment. Hit $500m mkt cap on completion of recruitment. And it hit $1bn mkt cap before results announced. They did have a deal with Acadia and ANP need to do a deal as well to hit those lofty heights pre results. I do think it is a high probability. We will see.
Bullish case - Terminal sales of ATL1102 could be as high as US$8 billion per year assuming a market penetration of 45% of all DMD boys in Europe and USA (20,000 boys out of a possible 44,000) with a sale price of US$400k. Sarepta drugs sell for US$750k. NEU sells for US$300k.
All guess work at the moment but going to be an interesting 12 months.
- Forums
- ASX - By Stock
- Ann: Trading Halt
@samfiodivingFunds raised get ANP to the end of the trial AND...
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.4¢ |
Change
0.004(5.00%) |
Mkt cap ! $75.72M |
Open | High | Low | Value | Volume |
8.0¢ | 8.4¢ | 8.0¢ | $26.89K | 328.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9602 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 58051 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9602 | 0.083 |
1 | 5500 | 0.082 |
1 | 75000 | 0.081 |
2 | 85000 | 0.080 |
2 | 27150 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 58051 | 1 |
0.085 | 106431 | 2 |
0.086 | 100000 | 1 |
0.087 | 125000 | 1 |
0.089 | 135000 | 2 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online